Market Place
Sourcing Support
Novo owner backs Swiss biotech Asceneuron in $100 million round
17 Jul 2024 //
REUTERS
Asceneuron Secures $100M For Neurodegenerative Disease Therapeutics
15 Jul 2024 //
PR NEWSWIRE
EQT Life Sciences Invests In Asceneuron`s Series C Financing Round
15 Jul 2024 //
PR NEWSWIRE
Asceneuron Joins Critical Path for Alzheimer`s Disease Consortium
26 Mar 2024 //
PR NEWSWIRE
Asceneuron Expands Scientific Advisory Board
06 Mar 2024 //
PR NEWSWIRE
Industry Veteran Abbas Hussain Appointed as Chair of Asceneuron
18 Dec 2023 //
PR NEWSWIRE
Asceneuron Awarded Second Grant from The Michael J. Fox Foundation
04 May 2022 //
PRNEWSWIRE
Asceneuron Publishes Pioneering PC Efficacy Data on ASN90 in AD/PD Models
01 Apr 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.